Bill > HB1332

This bill requires the Arkansas Medicaid Program and health benefit plans in the state to cover glucagon-like peptide-1 receptor agonists (GLP-1 agonists) when prescribed for weight loss. GLP-1 agonists are a class of medications primarily used to treat diabetes and obesity by helping to regulate blood sugar and reduce appetite. Specifically, the bill mandates that the Arkansas Medicaid Program cover these medications for weight loss purposes and directs the Department of Human Services to seek any necessary federal waivers or authorizations to implement this coverage. For private and government health benefit plans, the bill stipulates that they must provide coverage for GLP-1 agonists prescribed for weight loss starting January 1, 2026. For government self-insured plans, the coverage will be subject to the same provisions that apply to other services in their health benefit plans. This legislation aims to improve access to weight loss medications for Arkansas residents by requiring insurance coverage through Medicaid and private health plans.

Health and Social Services

https://arkleg.state.ar.us/Bills/Detail?id=hb1332&ddBienniumSession=2025%2F2025R